Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Red Light Holland ships pharmaceutical-grade psilocybin PEX010 to EU for clinical studies after acquiring Filament Health.
TRIP
$14.60
$0.00 0.00%

Red Light Holland ships pharmaceutical-grade psilocybin PEX010 to EU for clinical studies after acquiring Filament Health.

Company Fundamentals
16 Jul 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Red Light Holland, after acquiring Filament Health, has expanded its capabilities in pharmaceutical-grade psilocybin development. Filament completed a shipment of its botanical psilocybin drug candidate, PEX010, to the European Union to support multiple independent clinical studies, including collaborations with Nantes University Hospital and Karolinska Institutet. This shipment highlights growing demand for standardized natural psilocybin and strengthens Filament's role in global psychedelic research. The acquisition positions Red Light Holland as a global leader in psychedelic drug development and commercialization.

More News (TRIP)

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

In Q2 2026, Longleaf Small-Cap Fund saw positive contributions from New York real estate firms Alexander’s and Empire State Realty Trust, as well as travel company Tripadvisor. However, Boston Beer negatively impacted the quarter due to mixed short-t...

Market News
Neutral
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App